Theravance Biopharma, Inc. reports

Company location: George Town, Grand Cayman, CA
Fiscal year end: 31 December

Theravance Biopharma, Inc. has filed 1,125 SEC EDGAR filings since 01 Aug 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 726-750 of 1,000 matching filings.

Per page

25

Current page

30

4

FORM 4 -

Filing date: 03 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 03 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36033

8-K

Filing date: 02 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36033

8-K

Filing date: 01 May 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

CT ORDER File 001-36033

CT ORDER filing

Filing date: 19 Apr 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-36033

DEF 14A

Filing date: 21 Mar 2018
Reporting date: 01 May 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-223470

S-8

Filing date: 06 Mar 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-36033

10-K

Filing date: 28 Feb 2018
Reporting date: 31 Dec 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36033

8-K

Filing date: 27 Feb 2018
Reporting date: 27 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Feb 2018
Reporting date: 20 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Feb 2018
Reporting date: 20 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Feb 2018
Reporting date: 20 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Feb 2018
Reporting date: 20 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Feb 2018
Reporting date: 20 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Feb 2018
Reporting date: 20 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Feb 2018
Reporting date: 20 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Feb 2018
Reporting date: 20 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Feb 2018
Reporting date: 20 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 15 Feb 2018
Reporting date: 13 Feb 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .